-
-
Two recent clinical trials, rocket af and aristotle, have added two new direct thrombin inhibitors, in addition to dabigatran (RE-LY), to our armamentarium to prevent stroke in patients with atrial fibrillation.
-
Medication poisonings in children; rosuvastatin vs atorvastatin for atherosclerosis; saw palmetto for prostate symptoms; using atypical antipsychotics for off-label indications in adults; and FDA actions.
-
Extracorporeal membrane oxygenation is associated with a high mortality and a high incidence of neurological complications including stroke, subarachnoid hemorrhage, and brain death.
-
-
-
This issue might be subtitled "What will they think of next?" Getting high does not always require the purchase of illegal drugs, and all substances that alter sensorium, such as nutmeg, cannot be regulated. However, the emergency physician must remain aware of the latest fads of drug abuse, and should be able to recognize the symptoms they cause.
-
Not every patient experiencing shortness of breath needs to have definitive airway intervention such as intubation, says Sybil Murray, RN, an ED nurse at St. Anthony's Medical Center in St. Louis, MO.
-
Your next stroke patient may be aware there is a drug called tissue plasminogen activator (tPA), but he or she probably won't realize how few stroke patients are actually candidates for this treatment.
-
If your patient has aspirated prior to being intubated, he or she is at increased risk for ventilator-associated pneumonia (VAP), warns Nicole Schiever, RN, MSN, ED team leader at Riverside Medical Center in Kankakee, IL.